Background illustration for clinical trials search

Paid Clinical Trials Dallas

Discover 1,917 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Dallas TX, Austin TX, San Antonio TX, Fairway KS,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Dallas TX, Plano TX, Bedford TX, Carrollton TX,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Dallas TX, Tyler TX, Houston TX, Denver CO, Gilbert AZ,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: Dallas TX, Irving TX, Houston TX, Pueblo CO,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase3, Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: Dallas TX, Houston TX, Nashville TN, Littleton CO,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Dallas TX, The Woodlands TX, Houston TX, Alexandria LA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

for
Gastric Adenocarcinoma, Gastric Cancer,
Location: Dallas TX, Plano TX, Arlington TX, Bedford TX,
Sponsor: Toray Industries, Inc

Sex: All

Age: 18+

Code: NCT06038578

Phase2, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Dallas TX, Oklahoma City OK, Houston TX, Kansas City KS,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase1, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for
Small Cell Lung Cancer Extensive Stage
Location: Dallas TX, Tyler TX, St Louis MO, Lone Tree CO,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT05703971

Phase1, Phase2, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Dallas TX, Westwood KS, Iowa City IA, Atlanta GA,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase3, Recruiting

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Nashville TN, Denver CO, San Diego CA
Sponsor: Acepodia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06415487

Phase1, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Dallas TX, Fredericksburg TX, New Braunfels TX,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Dallas TX, Denison TX, Austin TX, The Woodlands TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Dallas TX, Austin TX, Houston TX, Tulsa OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase3, Recruiting

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

for
Advanced Lung Cancer
Location: Dallas TX, Tyler TX, Houston TX, Aurora CO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06892548

Phase1, Phase2, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Dallas TX, Bedford TX, Fort Worth TX, Shreveport LA,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Dallas TX, Germantown TN, Westwood KS, St Louis MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06926920

Phase1, Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Dallas TX, Austin TX, Houston TX, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

for
Regional Citrate Anticoagulation (RCA),
Location: Dallas TX, Memphis TN, Birmingham AL, Atlanta GA,
Sponsor: Vantive Health LLC

Sex: All

Age: 18+

Code: NCT05399537

Phase3, Recruiting

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas